CIPROFLOXACIN tablet, film coated

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

Ciprofloxacin hydrochloride (UNII: 4BA73M5E37) (Ciprofloxacin - UNII:5E8K9I0O4U)

Pieejams no:

RedPharm Drug Inc.

SNN (starptautisko nepatentēto nosaukumu):

Ciprofloxacin hydrochloride

Kompozīcija:

Ciprofloxacin 500 mg

Ievadīšanas:

ORAL

Receptes veids:

PRESCRIPTION DRUG

Ārstēšanas norādes:

Ciprofloxacin tablets are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. Please see DOSAGE AND ADMINISTRATION for specific recommendations. Urinary Tract Infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, Proteus mirabilis, Providencia rettgeri, Morganella morganii, Citrobacter diversus, Citrobacter freundii, Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus epidermidis, Staphylococcus saprophyticus, or Enterococcus faecalis. Acute Uncomplicated Cystitis in females caused by Escherichia coli or Staphylococcus saprophyticus. Chronic Bacterial Prostatitis caused by Escherichia coli or Proteus mirabilis. Lower Respiratory Tract Infections caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis, Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus parainfluenzae, or penicillin-suscept

Produktu pārskats:

Ciprofloxacin Tablets USP 100 mg are white, oval shaped film-coated tablets embossed with "R" on one side and "125" on other side and supplied in a cystitis pack containing 6 tablets for use only in female patients with acute uncomplicated cystitis. Cystitis package of 6                            NDC   55111-125-06 Ciprofloxacin Tablets USP 250 mg are white, oval shaped film-coated tablets embossed with "R" on one side and "126" on other side and are supplied in bottles of 50, 100, 500 and unit dose packages of 10 × 10. Bottles of 50                                         NDC   55111-126-50 Bottles of 100                                       NDC   55111-126-01 Bottles of 500                                       NDC   55111-126-05 Unit dose package of 10 × 10            NDC   55111-126-78 Ciprofloxacin Tablets USP 500 mg are white, oval shaped film-coated tablets embossed with "R" on one side and "127" on other side and are supplied in bottles of 50, 100, 500 and unit dose packages of 10 × 10. Bottles of 50                                         NDC   55111-127-50 Bottles of 100                                       NDC   55111-127-01 Bottles of 500                                       NDC   55111-127-05 Unit dose package of 10 × 10            NDC   55111-127-78 Ciprofloxacin Tablets USP 750 mg are white, modified capsule shaped film-coated tablets embossed with "R" on one side and "128" on other side and are supplied in bottles of 50, 100, 500 and unit dose packages of 10 × 10. Bottles of 50                                         NDC   55111-128-50 Bottles of 100                                       NDC   55111-128-01 Bottles of 500                                       NDC   55111-128-05 Unit dose package of 10 × 10            NDC   55111-128-78 Store below 86°F (30°C).

Autorizācija statuss:

Abbreviated New Drug Application

Lietošanas instrukcija

CIPROFLOXACIN - CIPROFLOXACIN TABLET, FILM COATED
RedPharm Drug Inc.
----------
MEDICATION GUIDE
CIPROFLOXACIN TABLETS, USP
CIPROFLOXACIN EXTENDED-RELEASE TABLETS
Read the Medication Guide that comes with ciprofloxacin tablets before
you start taking it and each time
you get a refill. There may be new information. This Medication Guide
does not take the place of talking
to your healthcare provider about your medical condition or your
treatment.
WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT
CIPROFLOXACIN TABLETS?
Ciprofloxacin belongs to a class of antibiotics called
fluoroquinolones. Ciprofloxacin tablets can cause
side effects that may be serious or even cause death. If you get any
of the following serious side effects,
get medical help right away. Talk with your healthcare provider about
whether you should continue to
take ciprofloxacin tablets.
Tendon rupture or swelling of the tendon (tendinitis)
•
Tendons are tough cords of tissue that connect muscles to bones.
•
Pain, swelling, tears, and inflammation of tendons including the back
of the ankle (Achilles),
shoulder, hand, or other tendon sites can happen in people of all ages
who take fluoroquinolone
antibiotics, including ciprofloxacin tablets. The risk of getting
tendon problems is higher if you:
•
are over 60 years of age
•
are taking steroids (corticosteroids)
•
have had a kidney, heart, or lung transplant.
•
Swelling of the tendon (tendinitis) and tendon rupture (breakage) have
also happened in patients
who take fluoroquinolones who do not have the above risk factors.
•
Other reasons for tendon ruptures can include:
•
physical activity or exercise
•
kidney failure
•
tendon problems in the past, such as in people with rheumatoid
arthritis (RA)
•
Call your healthcare provider right away at the first sign of tendon
pain, swelling or inflammation.
Stop taking ciprofloxacin tablets until tendinitis or tendon rupture
has been ruled out by your
healthcare provider. Avoid exercise and using the affected area. The
most common a

Produkta apraksts

CIPROFLOXACIN - CIPROFLOXACIN TABLET, FILM COATED
REDPHARM DRUG INC.
----------
CIPROFLOXACIN TABLETS, USP
BOXED WARNING
WARNING:
FLUOROQUINOLONES, INCLUDING CIPROFLOXACIN, ARE ASSOCIATED WITH AN
INCREASED RISK OF
TENDINITIS AND TENDON RUPTURE IN ALL AGES. THIS RISK IS FURTHER
INCREASED IN OLDER PATIENTS
USUALLY OVER 60 YEARS OF AGE, IN PATIENTS TAKING CORTICOSTEROID DRUGS,
AND IN PATIENTS WITH
KIDNEY, HEART OR LUNG TRANSPLANTS (SEE WARNINGS).
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of ciprofloxacin
tablets and other antibacterial drugs, ciprofloxacin tablets should be
used only to treat or prevent
infections that are proven or strongly suspected to be caused by
bacteria.
CLINICAL PHARMACOLOGY
ABS ORPTION
Ciprofloxacin given as an oral tablet is rapidly and well absorbed
from the gastrointestinal tract after
oral administration. The absolute bioavailability is approximately 70%
with no substantial loss by first
pass metabolism. Ciprofloxacin maximum serum concentrations and area
under the curve are shown in
the chart for the 250 mg to 1000 mg dose range.
DOS E
(MG)
MAXIMUM
SERUM CONCENTRATION
(ΜG/ML)
AREA
UNDER CURVE (AUC)
(ΜG·HR/ML)
250
1.2
4.8
500
2.4
11.6
750
4.3
20.2
1000
5.4
30.8
Maximum serum concentrations are attained 1 to 2 hours after oral
dosing. Mean concentrations 12 hours
after dosing with 250, 500, or 750 mg are 0.1, 0.2, and 0.4 µg/mL,
respectively. The serum elimination
half-life in subjects with normal renal function is approximately 4
hours. Serum concentrations increase
proportionately with doses up to 1000 mg.
A 500 mg oral dose given every 12 hours has been shown to produce an
area under the serum
concentration time curve (AUC) equivalent to that produced by an
intravenous infusion of 400 mg
ciprofloxacin given over 60 minutes every 12 hours. A 750 mg oral dose
given every 12 hours has
been shown to produce an AUC at steady-state equivalent to that
produced by an intravenous infusion of
400 mg given over 60 minutes every 8 hours. A 750 mg oral